REG - Morgan Stanley Cap - Rule 38.5 - Replacement of ABBVIE INC.

Morgan StanleyAnnouncement

14/04/2020 09:05

RNS Number : 5396J
  
Morgan Stanley Capital Services LLC
  
14 April 2020
  
 

AMENDMENT Section (2b) 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION




 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   09 APRIL 2020




 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales




 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  6,107


 79.9267 USD


 78.5600 USD




 




 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  20,163


 80.0100 USD


 79.0500 USD




 
 
(b)           Derivatives transactions (other than options transactions)
 




 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 16


 79.2300 USD




 CFD


 LONG


 575


 79.4102 USD




 CFD


 LONG


 6,000


 79.4789 USD




 CFD


 LONG


 166


 79.5135 USD




 CFD


 LONG


 561


 79.6351 USD




 CFD


 LONG


 4,007


 79.6351 USD




 CFD


 LONG


 500


 79.7000 USD




 CFD


 LONG


 100


 79.7000 USD




 CFD


 LONG


 851


 79.7500 USD




 CFD


 LONG


 43


 79.7551 USD




 CFD


 LONG


 1,819


 79.8354 USD




 CFD


 LONG


 1,700


 79.8406 USD




 CFD


 LONG


 736


 79.8432 USD




 CFD


 LONG


 16


 80.0100 USD




 CFD


 SHORT


 1,700


 79.1459 USD




 CFD


 SHORT


 12


 79.2400 USD




 CFD


 SHORT


 263


 79.5339 USD




 CFD


 SHORT


 881


 79.5536 USD




 CFD


 SHORT


 1,040


 79.6747 USD




 CFD


 SHORT


 5


 79.7500 USD




 CFD


 SHORT


 20


 79.7500 USD




 CFD


 SHORT


 125


 79.7500 USD




 CFD


 SHORT


 13


 79.7500 USD




 CFD


 SHORT


 87


 79.7500 USD




 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 




 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 




 
(ii) Exercising
 




 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  




 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 




Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 




 
 




 Date of disclosure


 14 APRIL 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEGIGDSDGBDGGS